researchers whose protocol specifically requires the KPV component would need to source KPV separately to build out the KLOW combination
Once the FDA completes rulemaking, BPC-157 is expected to become available by prescription through licensed compounding pharmacies
Furthermore, multiple studies have demonstrated that collagen peptides can inhibit the expression of pro-inflammatory factors, such as tumor necrosis factor-alpha (TNF-), interleukin-1 beta (IL-1), IL-6, IL-8, inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX-2), in fibroblasts and keratinocytes, thereby mitigating inflammatory responses [32, 33]
Koniver began ordering peptides from compounding pharmacies, which produce custom medications